RYTM - Rhythm Pharmaceuticals GAAP EPS of -$0.82 misses by $0.04 revenue of $19.2M beats by $4.17M
2023-08-01 07:15:14 ET
- Rhythm Pharmaceuticals press release ( NASDAQ: RYTM ): Q2 GAAP EPS of -$0.82 misses by $0.04 .
- Revenue of $19.2M (+111.9% Y/Y) beats by $4.17M .
For further details see:
Rhythm Pharmaceuticals GAAP EPS of -$0.82 misses by $0.04, revenue of $19.2M beats by $4.17M